What's The Price For Marketing A DESI Drug? Solvay Settles Estratest Class Action for $30 Million
This article was originally published in The Pink Sheet Daily
Executive Summary
Settlement in California follows claim that the hormone replacement therapy was in fact unapproved; a similar action is pending in Minnesota.